Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CanBas Co Ltd

+ Add to Watchlist

4575:JP

1,271.0 JPY 23.0 1.84%

As of 02:00:00 ET on 05/01/2015.

Snapshot for CanBas Co Ltd (4575)

Open: 1,205.0 Day's Range: 1,205.0 - 1,271.0 Volume: 39,100
Previous Close: 1,248.0 52wk Range: 548.0 - 2,959.0 1-Yr Rtn: +98.28%

Stock Chart for 4575

No chart data available.
  • 4575:JP 1,270.0
  • 1D
  • 1M
  • 1Y
1,248.0
Interactive 4575 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4575

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TPX -
Earnings Per Share (ttm) -96.7700
Est. EPS -
Est. PEG Ratio -
Market Cap (M JPY) 5,834.65
Shares Outstanding (M) 4.59
30 Day Average Volume 41,130
Price/Book (mrq) 6.5047
Price/Sale (ttm) 490.0133
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4575

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4575

CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.

Takumi KawabePresidentMakoto KatozumiDirector/CFO
Kazuyoshi SakamotoDirector
More Company Profile & Key Executives for 4575

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil